Tivanisiran
Tivanisiran (SYL1001) is a siRNA used for the study of dry eye disease. Tivanisiran was designed to silence transient receptor potential vanilloid 1 (TRPV1) mRNA[1].
Product Specifications
CAS Number
1848224-71-4
Product Name Alternative
SYL1001
UNSPSC
12352208
Target
Small Interfering RNA (siRNA) ; TRP Channel
Type
Oligonucleotides
Related Pathways
Epigenetics; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tivanisiran.html
Purity
97.48
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
[Tivanisiran]
Molecular Weight
12068.30 (AS: 5294.6 + SS: 6125.7)
References & Citations
[1]Anne-Marie Bleau, et al. Development of tivanisiran, a topical siRNA designed to|[2]Javier Moreno-Montañés, et al. Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opin Investig Drugs. 2018 Apr;27 (4) :421-426.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PLB45826-01 25 mg
(5- (2-Fluorophenyl) -1-pentyl-1H-pyrrol-3-yl) (naphthalen-1-yl) methanone
Sign In for Pricing
View Details PLB45826-02 50 mg
(5- (2-Fluorophenyl) -1-pentyl-1H-pyrrol-3-yl) (naphthalen-1-yl) methanone
Sign In for Pricing
View Details